Skip to main content

Advertisement

Table 2 Analysis of overall survival by VeriStrat classification and treatment

From: The serum-based VeriStrat® test is associated with proinflammatory reactants and clinical outcome in non-small cell lung cancer patients

Covariate Group Cox PH
p value
Log Rank
p value
VeriStrat Good 0.0002 0.0001
Poor
Treatment Erlotinib 0.6043 0.5985
Chemotherapy
Erlotinib Good < 0.0001 < 0.0001
Poor
Chemotherapy Good 0.2556 0.2520
Poor